Neuroendocrine tumor (NET) entities are rare malignancies. Higher awareness and improved diagnostic methods have led to an increasing incidence of these diseases, and most oncologists deal with such patients in their daily practice. The symposium on NETs that was held in Merano (Italy) in October 2009 was organized by the German-speaking European School of Oncology (dESO) and gathered specialists from different disciplines of transalpine countries to bring together experiences and observations regarding these tumors. The goal of the meeting and of this review was to illustrate both well- and poorly differentiated NETs and to encourage interdisciplinary approaches
Neuroendocrine tumor of the pancreas: What is new? Abstract. Neuroendocrine neoplasms are a rare and...
Because of the low incidence, and limited opportunities for large patient volume experiences, there ...
Introduction: Neuroendocrine tumors (NETs) occur more often in lungs, gastrointestinal tract, or pan...
Neuroendocrine tumours (NETs) are very rare diseases characterised by a high degree of histological ...
Introduction: Neuroendocrine tumors originate from chromaffin-like cells and are tumors with neuroe...
Neuroendocrine tumors (NET) are rare and heterogeneous diseases, whose prognosis is affected by seve...
Neuroendocrine tumors (NETs) originate from single or clustered neuroendocrine cells, distributed in...
Neuroendocrine tumors (NET) are malignant solid tumors that arise in hormone-secreting tissue of the...
Neuroendocrine tumours (NETs) represent a group of neoplasias characterized by significant histopath...
Professional as well as patient-oriented societies have contributed significantly to the development...
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endoc...
A panel of experts from Latin America convened in Brazil, in May of 2007, for consensus recommendati...
This section contains the reports of the meeting on neuroendocrine tumors held in Milan (May 2010). ...
Neuroendocrine tumors (NETs) arise from a variety of anatomic sites and share the capacity for produ...
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are rare neoplasms. They are varied in the...
Neuroendocrine tumor of the pancreas: What is new? Abstract. Neuroendocrine neoplasms are a rare and...
Because of the low incidence, and limited opportunities for large patient volume experiences, there ...
Introduction: Neuroendocrine tumors (NETs) occur more often in lungs, gastrointestinal tract, or pan...
Neuroendocrine tumours (NETs) are very rare diseases characterised by a high degree of histological ...
Introduction: Neuroendocrine tumors originate from chromaffin-like cells and are tumors with neuroe...
Neuroendocrine tumors (NET) are rare and heterogeneous diseases, whose prognosis is affected by seve...
Neuroendocrine tumors (NETs) originate from single or clustered neuroendocrine cells, distributed in...
Neuroendocrine tumors (NET) are malignant solid tumors that arise in hormone-secreting tissue of the...
Neuroendocrine tumours (NETs) represent a group of neoplasias characterized by significant histopath...
Professional as well as patient-oriented societies have contributed significantly to the development...
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endoc...
A panel of experts from Latin America convened in Brazil, in May of 2007, for consensus recommendati...
This section contains the reports of the meeting on neuroendocrine tumors held in Milan (May 2010). ...
Neuroendocrine tumors (NETs) arise from a variety of anatomic sites and share the capacity for produ...
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are rare neoplasms. They are varied in the...
Neuroendocrine tumor of the pancreas: What is new? Abstract. Neuroendocrine neoplasms are a rare and...
Because of the low incidence, and limited opportunities for large patient volume experiences, there ...
Introduction: Neuroendocrine tumors (NETs) occur more often in lungs, gastrointestinal tract, or pan...